EU remote
Medical Science Laison sHTG
About this role
The Medical Science Liaison (MSL) is a field-based scientific expert responsible for engaging healthcare professionals, clinical experts, and key external stakeholders in support of the agreed medical strategy for an innovative therapy for Familial Chylomicronemia Syndrome (FCS), with future potential in Severe Hypertriglyceridemia (sHTG). This position can be based in Frankfurt, Saarbrücken, Darmstadt and other cities in Germany.
In this role, you will drive scientific exchange, support clinical and evidence-generation initiatives, gather actionable insights, and partner cross-functionally to ensure consistent, high-quality scientific standards. The position plays a critical part in enhancing understanding of rare lipid disorders, supporting patient pathways, and enabling informed, ethical decision-making. Executes field medical activities in accordance with Medical Excellence standards, including qualitative insights capture, engagement planning discipline, and agreed performance measures.
Key Responsibilities Build meaningful scientific partnerships Act as a trusted field-based medical and scientific expert for our product within the FCS and sHTG communities. Develop and maintain strong, long-term relationships with KOLs, healthcare professionals and academic researchers. Engage in high-quality, non-promotional scientific discussions around disease pathways, clinical evidence, patient management and emerging data, always using approved medical content.
Foster balanced, scientifically rigorous dialogue and communicate relevant information clearly and effectively. Develop and maintain stakeholder engagement plans in line with Medical Excellence guidance, including stakeholder segmentation, engagement objectives, scientific exchange plans and appropriate documentation. Turn insights into impact Capture meaningful, actionable insights from interactions with HCPs, scientific meetings and other stakeholder activities.
Bring the external perspective into Medical Affairs by sharing insights that can help shape: Medical strategy Evidence-generation priorities Stakeholder engagement plans Educational initiatives Key account plans and cross-functional activities Identify emerging challenges and opportunities across diagnosis, treatment access and unmet patient needs. Contribute to regular insight reviews, including monthly and quarterly discussions, helping to strengthen cross-country visibility and inform strategic decision-making.